Skip to content
Open access

Lipoprotein(a) and the C-reactive protein-triglyceride-glucose index in relation to coronary lesion burden in patients with acute coronary syndrome.

Sep 2026 · Journal of Lipid Research · Vol 67, pp. 101135 · 0 citations · 57 references
Medicine

TL;DR

Among inflammatory-lipid indices, CTI showed the most consistent associations and provided the largest numerical incremental discrimination beyond Lp(a) and CTI level, and may complement Lp(a) by capturing inflammatory-metabolic status for more refined characterization of lesion-burden risk in ACS.

Abstract

Background

Lipoprotein(a) [Lp(a)] reflects inherited atherothrombotic risk, whereas the C-reactive protein-triglyceride-glucose index (CTI) integrates systemic inflammation, triglyceride-related lipid disturbance, and glucose-related metabolic stress. Their individual and joint association with angiographic coronary lesion burden in acute coronary syndrome (ACS) remain incompletely defined. We examined whether CTI complements Lp(a) in characterizing coronary lesion burden in ACS.

Materials And Methods

This retrospective, single-center study included 2,836 consecutive patients with ACS who underwent coronary angiography. Coronary lesion burden was assessed using continuous Gensini score, a high Gensini score, and multivessel disease (MVD). Multivariable regression, restricted cubic spline analyses, CTI-stratified analyses, incremental receiver operating characteristic analyses, and internally validated machine-learning analyses with SHAP interpretation were performed.

Results

Higher Lp(a) and CTI level were both associated with greater coronary lesion burden. Compared with Lp(a) <75 nmol/L, Lp(a) ≥175 nmol/L was associated with high Gensini score (OR, 1.51 [95% CI, 1.17-1.96]) and MVD (OR, 1.69 [95% CI, 1.27-2.26]). Each 1-SD increase in CTI was associated with high Gensini score (OR, 1.47 [95% CI, 1.35-1.60]) and MVD (OR, 1.18 [95% CI, 1.08-1.28]). Among inflammatory-lipid indices, CTI showed the most consistent associations and provided the largest numerical incremental discrimination beyond Lp(a). The associaton between ver high Lp(a) and coronary lesion burden was more pronounced at higher CTI levels, particular for MVD. Machine-learning analyses further supported the relevance of both CTI and Lp(a).

Conclusions

In patients with ACS, higher Lp(a) and CTI level were associated with greater angiographic coronary lesion burden. CTI may complement Lp(a) by capturing inflammatory-metabolic status, supporting their joint assessment for more refined characterization of lesion-burden risk in ACS.

Read PDF

Similar papers

Open access Aug 2026

Association of the cholesterol-high-density lipoprotein-glucose index with coronary atherosclerotic burden in patients with coronary artery disease

A higher CHG index was associated with a higher Gensini score in patients with CAD, suggesting that this simple and inexpensive metabolic marker may provide complementary information for assessing coronary atherosclerotic burden.

Jia-Yu Zhang, Hong-Xin Dong, Sheng Lei et al. · 0 citations
Sep 2026

Joint association of high-sensitivity C-reactive protein-triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study.

In patients with CAD, elevated CTI and MSCAC independently portend adverse outcomes, and their coexistence identifies a particularly high‑risk phenotype, which supports the complementary value of metabolic‑inflammatory and anatomic measures in risk stratification.

Song Wen, Zhan-Yuan Chen, Rui Fu et al. · 0 citations
Open access Aug 2026

Association of the c-reactive protein-triglyceride glucose index with myocardial ischemia in patients with minimal to moderate coronary artery disease

Objective This study sought to explore the relationship between the C-reactive protein-triglyceride-glucose index (CTI) and the incidence of myocardial ischemia in patients with minimal to moderate coronary artery disease (CAD). Methods The research retrospectively included 707 patients who underwent coronary computed...

Zeng-Fa Huang, Beibei Cao, Xiao-Yu Liu et al. · 0 citations
Open access Aug 2026

C-reactive protein–triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with H-type hypertension

The C-reactive protein–triglyceride glucose index (CTI) is a novel composite biomarker that integrates inflammation and insulin resistance. However, its association with the severity of coronary artery disease (CAD) in patients with H-type hypertension under different glucose metabolism statuses remains unclear. This r...

Li Luo, Lian Wang, Xiang-Bing Yu et al. · 0 citations
Open access Aug 2026

Associations between triglyceride-glucose-derived indices combined with the atherogenic index of plasma and the precise severity of newly diagnosed coronary artery disease: a quantile regressions analysis

Background Metabolic dysfunction, including insulin resistance, inflammation, and dyslipidaemia, plays a critical role in the development of coronary artery disease (CAD). The triglyceride-glucose (TyG) index, the C-reactive protein-triglyceride-glucose index (CTI), and the atherogenic index of plasma (AIP) are accessi...

Run-Zhe Wu, Cong-Ying Wang, Lu-Lu Pan et al. · 0 citations
Sep 2026

Lipoprotein(a)-to-HDL-C ratio and risk of repeat revascularization and in-stent restenosis after PCI in patients with chronic coronary syndrome undergoing follow-up coronary imaging.

BACKGROUND We proposed a novel lipoprotein(a)-to-HDL-C ratio (LHR) and examined its association with repeat revascularization and in-stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) after percutaneous coronary intervention (PCI). METHODS A total of 2,238 patients with CCS undergoing DES-PCI who...

Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.